Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000294889

Medchemexpress LLC 6-(4-(1-aminocyclobutyl)phenyl)-5-phenylnicotinamide | 1357158-81-6 | >98.0% | 343.42 g/mol | C22H21N3O | 10 MG
SDP

Catalog No. 5000294889
Encompass_Preferred

AKT-IN-1 is a small-molecule allosteric inhibitor of the AKT kinase family used for pathway and cancer research. It inhibits AKT with an IC50 of 1.042 μM, has CAS 1357158-81-6, and is supplied as a research-grade solid with high purity for biochemical and cellular assays.

  • Allosteric AKT inhibition with IC50 = 1.042 μM.
  • High chemical purity for reproducible results.
  • Suitable for PI3K/Akt/mTOR pathway studies and cancer research.
  • Solid form enabling flexible solution preparation.
  • Molecular weight 343.42 g/mol and formula C22H21N3O for accurate dosing.
  • Intended for research use only.

Catalog No. 50-002-94889 Supplier Medchemexpress LLC Supplier No. HY1829610MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

AKT-IN-1 is a small-molecule allosteric inhibitor of the AKT kinase family used for pathway and cancer research. It inhibits AKT with an IC50 of 1.042 μM, has CAS 1357158-81-6, and is supplied as a research-grade solid with high purity for biochemical and cellular assays.

  • Allosteric AKT inhibition with IC50 = 1.042 μM.
  • High chemical purity for reproducible results.
  • Suitable for PI3K/Akt/mTOR pathway studies and cancer research.
  • Solid form enabling flexible solution preparation.
  • Molecular weight 343.42 g/mol and formula C22H21N3O for accurate dosing.
  • Intended for research use only.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.